Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on May 13, 2025
TigerConnect Fortalece Presencia Global con Nueva Oficina en Ciudad de México
GlobeNewswire
·
May 13, 2025
CIUDAD DE MÉXICO, May 13, 2025 (GLOBE NEWSWIRE) -- TigerConnect, la principal plataforma unificada de comunicaciones para el cuidado de la salud anunció hoy la apertura de su nueva oficina regional en Ciudad de México. Ubicada en el corazón de Reforma, el …
Athira Pharma to Present Data from First-in-Human Phase 1 Clinical Trial of ATH-1105 at the 4th Annual ALS Drug Development Summit
GlobeNewswire
·
May 13, 2025
Data from Phase 1 clinical trial of ATH-1105 in healthy volunteers showed a favorable safety and tolerability profile; dose proportional pharmacokinetics and CNS penetration support continued clinical development On-track to enable initiation of a clinical …
DANDY® CELERY LAUNCHES “SHUCK & SMILES” CONSUMER SWEEPSTAKES
GlobeNewswire
·
May 13, 2025
Oviedo, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Dandy® Produce, a leading grower of fresh celery, radish and corn in the U.S., launches the “Shucks …
AscellaHealth Awarded on the Financial Times Americas’ Fastest Growing Companies 2025 List!
GlobeNewswire
·
May 13, 2025
BERWYN, Pa., May 13, 2025 (GLOBE NEWSWIRE) -- AscellaHealth has been awarded on the Financial Times list of The Americas’ Fastest Growing Companies 2025. This prestigious award is presented by Financial Times and Statista Inc., the world-leading statistics …
ARC Fertility Wins 2025 MedTech Breakthrough Award for Best Reproductive Health Technology Solution
GlobeNewswire
·
May 13, 2025
CUPERTINO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for employers and their employees, has been named the winner of the 2025 MedTech …
Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market
GlobeNewswire
·
May 13, 2025
Discussion in Virtual Investor CEO Connect focuses on Company’s planned follow-on market expansion study phase (“PoC 2”) of proof-of-concept trial; Access Here Additional indications potentially double the addressable market beyond pancreatic cancer pain …
Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data
GlobeNewswire
·
May 13, 2025
MELVILLE, N.Y., May 13, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, is pleased to …
Serotonin Centers Announces Landmark Southeast Florida Area Development
GlobeNewswire
·
May 13, 2025
MIAMI and FORT LAUDERDALE, Fla. and PALM BEACH, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Serotonin Anti-Aging Centers (Serotonin Centers), the premier national anti-aging/longevity franchise, announced today a landmark multi-unit development agreement with …
Complement 1 Secures $16M Seed Round to Scale Clinically Validated Cancer Lifestyle Modification Platform
GlobeNewswire
·
May 13, 2025
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Complement 1, a health tech startup transforming cancer care through personalized lifestyle medicine, today announced a $16 million oversubscribed seed funding round led by Owl Ventures and Blume Ventures. The …
Visory Health Expands Veteran Support Through New Partnership with Hope for the Warriors
GlobeNewswire
·
May 13, 2025
ESTERO, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Visory Health, a patient-first health tech prescription platform that is transforming the way Veterans, families, and caregivers access affordable healthcare through its prescription discount card, proudly …
Ensemble Announces Strategic Revenue Cycle Partnership with Jupiter Medical Center
GlobeNewswire
·
May 13, 2025
Cincinnati, OH, May 13, 2025 (GLOBE NEWSWIRE) -- Ensemble, the nation’s leading revenue cycle managed services partner for healthcare organizations, announced today it has been selected by Jupiter Medical Center as their strategic revenue cycle management …
Doheny Eye Institute Announces Kaustabh Ghosh, Ph.D. as the Mary D. Allen Endowed Chair in Vision Research
GlobeNewswire
·
May 13, 2025
PASADENA, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions for more than 75 years, is proud to announce that Kaustabh Ghosh, Ph.D., has been awarded the Mary D. Allen Endowed Chair in …
General Oncology to Participate in Three Upcoming Conferences
GlobeNewswire
·
May 13, 2025
BOSTON, May 13, 2025 (GLOBE NEWSWIRE) -- General Oncology, Inc., a clinical-stage biopharmaceutical company dedicated to pioneering first-in-class treatments for metastatic cancers, today announced that members of its senior management team will …
AVITA Medical’s Acute Wound Care Showcase 2025 Streams Live Today
GlobeNewswire
·
May 13, 2025
VALENCIA, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, is hosting its Acute Wound Care Showcase 2025 virtually today, May 13, 2025 …
CytoDyn Announces Data Suggesting Novel Mechanism of Action of Leronlimab for the Treatment of Solid Tumors
GlobeNewswire
·
May 13, 2025
Survival observations in mTNBC patients correlated with increased PD-L1 expression Preliminary evidence suggests leronlimab has potential to turn “cold” tumors “hot” VANCOUVER, Washington, May 13, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (" …
Adial Pharmaceuticals Receives Milestone Payment from Adovate Following Initiation of Phase 1 Study
GlobeNewswire
·
May 13, 2025
Glen Allen, Va., May 13, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related …
Tenaya Therapeutics to Highlight Capsid Engineering, Gene Editing and Manufacturing Research at the ASGCT 28th Annual Meeting
GlobeNewswire
·
May 13, 2025
SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes …
Excision BioTherapeutics Presents Data from HBV and HSV Programs at the ASGCT 2025 Annual Meeting
GlobeNewswire
·
May 13, 2025
Poster presentation to demonstrate EBT-107’s potential to reduce clinically-relevant biomarkers and HBV DNA integration toward functional remission of chronic hepatitis B Oral presentation to highlight significant reduction in HSC-1 viral load in the …
Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia
GlobeNewswire
·
May 13, 2025
SARASOTA, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel intranasal therapies for brain-related disorders, today announced that it has received approval from the Human …
Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer’s Program Amid Encouraging Data
GlobeNewswire
·
May 13, 2025
HOUSTON, TX, May 13, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the reconstitution of its Scientific …